News in treatment of angiomas

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 2, 2004, Pages 122-123

  Benedetto, A V ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; AMINOTRANSFERASE; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; CORTICOSTEROID; FIBROBLAST GROWTH FACTOR; ISOTRETINOIN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ANEMIA; ANGIOMA; CANCER INHIBITION; CELL PROLIFERATION; DRUG MECHANISM; EDITORIAL; ENDOTHELIUM CELL; EXCISION; FLU LIKE SYNDROME; HUMAN; LEUKOCYTOSIS; NEOVASCULARIZATION (PATHOLOGY); NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SPASTIC PARESIS; VASCULAR TUMOR;

ANGIOGENESIS INHIBITORS; COMBINED MODALITY THERAPY; HEMANGIOMA; HUMANS; INTERFERON ALFA-2A;

EID: 1642271477     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00845.x     Document Type: Editorial

References (16)

1. Folkman J, Ingber D. Inhibition of angiogenesis. Semin Cancer Biol 1992; 3: 89-96.
2. Battegay EJ. Angiogenesis: Mechanistic insights, neovascular disease, and therapeutic prospects. J Mol Med 1995; 73: 333-346.
3. Marler JJ, Rubin JB, Trede NS et al. Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: Report of 2 cases. Pediatrics 2002; 109: E37.
4. Garmendia G, Miranda N, Borroso S et al. Regression of infancy hemangiomas with recombinant IFN-alpha 2b. J Interferon Cytokine Res 2001; 21: 31-38.
5. Niemela M, Maenpaa H, Salven P et al. interferon alpha-2a therapy in 18 hemangioblastomas. Clin Cancer Res 2001; 7: 510-516.
6. Fledelius HC, Illum N, Jensen H, Prause JU. Interferon-alfa treatment of facial infantile hemangiomas: With emphasis on the sight-threatening varieties. A clinical series. Acta Ophthalmol Scand 2001; 79: 370-373.
7. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 326: 1456-1463.
8. Rampini E, Rampini P, Occella C, Bleidl D. Interferon alpha 2b for treatment of complex cutaneous hemangiomas of infancy: A reduced dosage schedule. Br J Dermatol 2000; 142: 189 -191.
9. Greinwald JH Jr, Burke DK, Bouthius DJ et al. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999; 125: 21-27.
10. Blei F, Orlow SJ, Geronemus RG. Interferon alfa-2a therapy for extensive perianal and lower extremity hemangioma. J Am Acad Dermatol 1993; 29: 98-99.
11. Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy. When to worry, what to do. Arch Dermatol 2000; 136: 905-914.
12. Chang E, Boyd A, Nelson CC et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997; 19: 237-244.
13. Suarez SM, Pensler JM, Paller AM. Response of deep tufted angioma to interferon alfa. J Am Acad Dermatol 1995; 33: 124-126.
14. Bernstein EF, Kantor G, Howe N et al. Tufted angioma of the thigh. J Am Acad Dermatol 1994; 31: 307-311.
15. Léauté-Labrèze C, Bioulac-Sage P, Labbé L et al. Tufted angioma associated with platelet trapping syndrome: Response to aspirin. Arch Dermatol 1997; 133: 1077-1079.
16. Spieth K, Gille J, Kauffmann R. Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head. Arch Dermatol 1999; 135: 1035-1037.